Arrowhead Pharmaceuticals (ARWR) FCF Margin Growth (3y) (2013 - 2026)
Arrowhead Pharmaceuticals (ARWR) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15,064.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arrowhead Pharmaceuticals | 11.98 Bn | 10.18 Bn | - | 15,137.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,137.00 |
| Dec 31, 2025 | 18,724.00 |
| Sep 30, 2025 | 32,931.00 |
| Jun 30, 2025 | -27,058.00 |
| Mar 31, 2025 | 4,469.00 |
| Dec 31, 2024 | -570,935.00 |
| Dec 31, 2023 | -504,917.00 |
| Sep 30, 2023 | -98,973.00 |
| Jun 30, 2023 | 31,837.00 |
| Mar 31, 2023 | 9,225.00 |
| Dec 31, 2022 | -8,840.00 |
| Jun 30, 2022 | -36,528.00 |
| Mar 31, 2022 | -14,024.00 |
| Dec 31, 2021 | -72,792.00 |
| Jun 30, 2021 | 193,512.00 |
| Mar 31, 2021 | 321,603.00 |
| Dec 31, 2020 | 21,966.00 |
| Sep 30, 2020 | -6,536.00 |
| Jun 30, 2020 | -610.00 |
| Mar 31, 2020 | 4,195.00 |